🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

10 recruiting trials

for Charcot-Marie-Tooth Disease, Type Ia (Disorder)

A First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of EDK060 in Adults With CMT1A. NCT07140614Phase 14 sites📍 Ottawa📍 Montreal📍 Montreal Novartis Pharmaceuticals · Tests: EDK060, dose A, EDK060, dose B, EDK060, dose C, EDK060, dose D, Placebo Clinical Trial Evaluating the Impact of an Intensive Rehabilitation Program Combined With Tendon Vibratory Stimulation on Functional Balance in Individuals With Charcot-Marie-Tooth Disease Type 1A NCT07726043NA1 site📍 Marseille UGECAM PACA et Corse · Tests: Multidisciplinary rehabilitation program Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2 NCT01193088n/a24 sites📍 Los Angeles📍 Palo Alto📍 Aurora University of Iowa A Multi-omic Approach to the Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease (CMT1A) NCT07476365n/a1 site📍 Göttingen University Medical Center Goettingen Natural History Study for Charcot Marie Tooth Disease NCT05902351n/a1 site📍 New York Hereditary Neuropathy Foundation AUTONOMOUS DISORDERS IN CMT NCT07570446n/a1 site📍 Göttingen University Medical Center Goettingen Longitudinal Biomarkers With Selected Outcome Measures In CMT NCT06794489n/a1 site📍 Göttingen University Medical Center Goettingen Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease NCT07049588NA1 site📍 Marseille Assistance Publique Hopitaux De Marseille · Tests: Quantitative neuromuscular MRI, Skin biopsy, Clinical scores, Blood test, Patient Report Outcomes Measures Studying Nerve Function and Structure in Charcot-Marie-Tooth Disease, Anti-MAG Neuropathy and CIDP NCT07461896n/a1 site📍 Milan Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta Evaluate the Safety and Efficacy of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A(CMT1A) (Phase 1b: Open-label, Dose-escalation, Single-center; Phase 2a: Randomized, Double-blind, Placebo-controlled, Multicenter) NCT06328712Phase 1, Phase 23 sites📍 Gyeongju📍 Seoul📍 Seoul ENCell · Tests: EN001, EN001 Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy